QIAstat-Dx BCID GPF Plus AMR Panel
Rapidly identify common bloodstream pathogens and AMR markers to support faster, more informed treatment decisions.
Receive your quote directly from the manufacturer.
The QIAstat-Dx BCID GPF Plus AMR Panel is a multiplex syndromic test designed for rapid, comprehensive detection of bloodstream infection pathogens and associated antimicrobial resistance markers. It delivers actionable results directly from positive blood culture samples to support timely, targeted therapy decisions.
Comprehensive bloodstream infection coverage
This panel is optimized for broad detection of gram-positive bacteria, gram-negative bacteria, fungi, and key antimicrobial resistance determinants in a single run. It is intended for use with the QIAstat-Dx Analyzer, integrating sample processing, nucleic acid amplification, and detection in a closed, cartridge-based system to minimize hands-on time.
Streamlined workflow for clinical laboratories
The QIAstat-Dx BCID GPF Plus AMR Panel is designed to fit seamlessly into routine microbiology workflows, from sample loading to result interpretation. Automated processing reduces manual steps and variability, while standardized assay conditions support consistent performance across runs and operators.
Actionable results to support antimicrobial stewardship
By combining pathogen identification with detection of critical antimicrobial resistance markers, the panel helps clinicians refine empiric therapy and support antimicrobial stewardship initiatives. Rapid, syndromic results can aid in optimizing patient management, improving laboratory efficiency, and supporting infection control strategies.
Key features and benefits of QIAstat-Dx BCID GPF Plus AMR Panel:
- Multiplex syndromic panel for broad detection of bloodstream infection pathogens
- Integrated workflow on the QIAstat-Dx Analyzer for minimal hands-on time
- Simultaneous identification of organisms and antimicrobial resistance markers
- Closed, cartridge-based system to reduce contamination risk
- Supports faster, more informed antimicrobial therapy decisions
Brochures
Global QIAstat-Dx syndromic testing solutions and bloodstream infection portfolio
This product brochure showcases the global QIAstat-Dx® syndromic testing portfolio for rapid detection of infectious disease pathogens across multiple clinical syndromes. Discover how the system enables fast identification of respiratory, gastrointestinal, meningitis/encephalitis, and bloodstream infection targets, including key antimicrobial resistance markers. Discover the advantages of one-step sample processing, multiplex RT-PCR technology, integrated cloud connectivity through QIAsphere®, and epidemiological monitoring tools that help laboratories support diagnostic and antimicrobial stewardship initiatives.
Resource details:
Resource type: Product brochure
Page count: 20
Read time: 15 min
U.S. FDA-cleared QIAstat-Dx syndromic testing solutions
This product brochure introduces the QIAstat-Dx® syndromic testing portfolio, highlighting rapid multiplex PCR solutions for respiratory, gastrointestinal, meningitis/encephalitis, and bloodstream infections. Discover how the platform delivers comprehensive pathogen detection, antimicrobial resistance insights, and clinical context from a single sample with minimal hands-on time. Explore the benefits of integrated connectivity, epidemiology monitoring through QIAsphere®, and flexible instrument configurations that support faster diagnosis, improved infection control, and more informed treatment decisions.
Resource details:
Resource type: Product brochure
Page count: 20
Read time: 15 mins
